NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Infosys' FY27 Organic Growth Guidance Lower Than Expected

Infosys has provided its organic growth guidance for FY27, which is 2.2% year-over-year (YoY) constant currency (CC) at the mid-point. This is lower than the 2.4% organic growth delivered in FY26. Despite strong bookings and a better exit rate compared to last year, the decline in organic growth guidance can be attributed to three main factors: client-specific issues in a large European manufacturing client, a lower onsite revenue mix, and AI-led compression.

The research report highlights that Infosys has executed well in improving realisation in FY26, with deal total contract value (TCV) growth of 28% YoY. However, the company has faced increased competitive intensity due to rapid advancements in AI, which adds to the uncertainty surrounding the quantum of AI-led compression.

Furthermore, Infosys' management has acknowledged the impact of increased uncertainty on the company's growth prospects. This is reflected in the slower addition of headcount and the deferment of wage hikes for FY26.

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

FY26 vs FY27 GuidanceFY26FY27 Guidance
Organic Growth (YoY CC)2.4%2.2%
Deal TCV Growth (YoY)28%-
RealisationImproved-

Based on the analysis, we maintain a HOLD recommendation for Infosys with a target price (TP) of INR 1,300. This is based on a one-year forward unchanged price-to-earnings (P/E) ratio of 17x on FY28 earnings per share (EPS) of INR 76.6.

Investor Takeaway

Maintain HOLD with a target price of INR 1,300.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.